Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 1, 1999, Pages 59-64

  Yamada, Manabu ^a,b   Tomida, Akihiro ^a   Yun, Jisoo ^a   Cai, Bing ^a   Yoshikawa, Hiroyuki ^b   Taketani, Yuji ^b   Tsuruo, Takashi ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Carboplatin; Chemosensitization; Cisplatin; DNA platination; Glucose regulated stress

Indexed keywords

CALCIMYCIN; CAMPTOTHECIN; CARBOPLATIN; CISPLATIN; DEOXYGLUCOSE; DOXORUBICIN; ETOPOSIDE; GLUCOSE REGULATED PROTEIN; PLATINUM; TUNICAMYCIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CHEMOSENSITIVITY; DNA ADDUCT; DNA BINDING; DNA DRUG COMPLEX; DRUG POTENCY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; SOLID TUMOR; STARVATION; STRESS;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CELL CYCLE; CELL DIVISION; CISPLATIN; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE; HUMANS; OVARIAN NEOPLASMS; OXIDATIVE STRESS; TUMOR CELLS, CULTURED;

EID: 0032992249     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050945     Document Type: Article

References (27)

1. Bosl GJ, Bajorin DF (1994) Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison. Semin Oncol 21: 61
2. Cai JW, Henderson BW, Shen JW, Subjeck JR (1993) Induction of glucose regulated proteins during growth of a murine tumor. J Cell Physiol 154: 229
3. Chaney GS, Sancar A (1996) DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 88: 1346
4. Chu G (1994) Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269: 787
5. Colofiore JR, Ara G, Berry D, Belli JA (1982) Enhanced survival of Adriamycin-treated Chinese hamster cells by 2-deoxy-D-glucose and 2,4-dinitrophenol. Cancer Res 42: 3934
6. Evans DL, Tilby M, Dive C (1994) Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res 54: 1596
7. Forastiere AA (1994) Overview of platinum chemotherapy in head and neck cancer. Semin Oncol 21: 20
8. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89: 3070
9. Hughes CS, Shen JW, Subjeck JR (1989) Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res 49: 4452
10. Ishikawa T, Ali-Osman F (1993) Glutathione-associated cisdiamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem 268: 20116
11. Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC (1994) Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res 54: 5911
12. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813
13. Lai G-M, Ozols RF, Smyth JF, Young RC, Hamilton TC (1988) Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem Pharmacol 37: 4597
14. Lee AS (1987) Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biochem Sci 12: 20
15. Oldenburg J, Begg AC, von Vugt MJH, Ruevekamp M, Schornagel JH, Pinedo HM, Los G (1994) Characterization of resistance mechanisms to cis-diaminedichloroplatinum (II) in three sublines of the CC531 adenocarcinoma cell line in vitro. Cancer Res 54: 487
16. Ozols RF (1992) New developments with carboplatin in the treatment of ovarian cancer. Semin Oncol 19: 85
17. Parker RJ, Eastman A, Bosstick-Bruton F, Reed E (1991) Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest 87: 772
18. Reedijk J (1987) The mechanism of action of platinum anti-tumor drugs. Pure Appl Chem 59: 181
19. Rockwell S (1992) Use of hypoxia-directed drugs in the therapy of solid tumors. Semin Oncol 19: 29
20. Shen J, Hughes C, Chao C, Cai J, Bartels C, Gessner T, Subjeck J (1987) Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc Natl Acad Sci USA 84: 3278
21. Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177
22. Tomida A, Naito M, Tsuruo T (1995) Acute induction of Adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of Adriamycin. Jpn J Cancer Res 86: 224
23. Tomida A, Yun J, Tsuruo T (1996) Glucose-regulated stresses induce resistance to camptothecin in human cancer cells. Int J Cancer 68: 391
24. Udagawa Y, Nozawa S, Chin K, Kubushiro K, Sakuma T, Iino K, Izumi S (1988) Establishment and characterization of the ovarian cancer cell line (RTSG) producing human chorionic gonadotropin (in Japanese). Hum Cell 1: 348
25. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449
26. Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T (1996) Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines. Clin Cancer Res 2: 427
27. Yun J, Tomida A, Nagata K, Tsuruo T (1995) Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II. Oncol Res 7: 583